The cancer therapy market is largely driven by increasing global prevalence of cancer; hence, cancer therapies must be modified according to regional and national priorities. According to the World Cancer Research Fund, in 2018, there were an estimated 18 million cancer cases, around the world, out of which, 9.5 million cases were in men and 8.5 million in women. Lung and breast cancers were the most common, globally, and they contributed 12.3% of the total number of new cases that were diagnosed in 2018. Along with this, due to the rising prevalence of cancer in every part of the world, various governments, around the world, have established various initiatives for cancer awareness that are illustrating broad approaches for preventing and monitoring cancer.

Asthma in older adults has a notable impact on the elderly's quality of life. Asthma coincides with conditions such as obesity, decreased immunity, and chronic obstructive pulmonary disease (COPD), which are most common among this age population. Therefore, asthma can often be complicated and difficult to spot in the elderly and it often goes. Population Census 2011 stated that, there are nearly 104 million elderly population who are aged 60 years or above in India. Out of which 53 million are females and 51 million males. A report published by the United Nations Population Fund and HelpAge India states that the number of elderly persons is expected to grow to 173 million by 2026. Moreover, as per the National Center for Biotechnology Information (NCBI), China's elderly population is expanding more rapidly than the total population. The elderly population rose from 42 million in 1953 to 72 million in 1978. According to UN projection, China's elderly population will rise to 11% by the end of the century and 20% by 2025. The factors for the increase in the elderly population are a better standard of living and health care, a declining birth rate, longer life expectancy, and aging baby boom cohorts born in the last 30 years. Additionally, as per the Nippon Communications Foundation, In Tokyo, the total number of population aged over 75 will rise from 1.47 million in 2015 to 2.27 million in 2045.

Advancement in the field of patient simulators has enhanced the market. Many industry players have come up with innovative types of simulators in the last few years. The advancement in the simulators has led to faster and easier treatment and recovery of patients. Also, the investments from public and private investors are rising for the simulators. To improvise the technique, there have been various innovations as well as developments in the field. There have been numerous image enhancement innovations in recent years to enable better usage of simulators. New technologies were developed to reduce the time of the surgeons and the patients. For instance, in April 2017, Japanese researchers created a 3D printed robot to practice medical simulation. The robot named ‘Mikoto’, had realistic 3D printed organs, which provided a better realistic training simulation experience for medical students. The robot had initially been developed for three medical procedures: endotracheal intubation, gastrointestinal endoscopy and sputum suctioning. The robot is also equipped with various signals that sense pressure and pain and accordingly release signals and alert the practitioners. Thus, the innovative steps and technological advancements undertaken by new entrants as well as established market players to improve the quality and efficacy of patient simulators is expected to favour the growth of the market in the years to come..

The report provides market dynamics and trends related to the global antihypertensive drugs market. In addition, it presents the estimations and forecast of the market. It includes revenue generated from the sales of products such as diuretics, ACE inhibitors, calcium channel blockers, beta-adrenergic blockers, vasodilators, and others, which are provided by key players. For the purpose of analysis, the global antihypertensive drugs market is segmented into therapeutic class, distribution channel, and region. The study estimates the revenue generated from the sale of antihypertensive drugs through various distribution channel such as retail pharmacy, hospital pharmacy, and e-commerce websites & online drug stores. This further provides an understanding of the use of antihypertensive drugs. Moreover, the report covers the revenue generated from the sales of antihypertensive drugs offered in regions such as North America, Europe, Asia-Pacific, and LAMEA.

In the mid-20th century, the advancement in cardiac surgery has created a need and demand for an artificial source that helps in stimulating the heart muscle. Initially, the scientist developed large-size external devices causing discomfort in patients. Later, the advancement in technology has resulted in the miniaturization of electronic circuitry and eventually the development of totally implantable devices. These advancements continue till date, with the recent introduction of leadless pacemakers, that are directly implanted within the cardiac chamber.

The market studied is currently being driven by factors, such as the rising incidence of orthopedic, cardiac and neurosurgery, increasing number of surgical procedures, and technological advancements. Biosurgery products are used in various surgeries and repair weakened and damaged tissues and bones. Biosurgery has opened a new paradigm in surgical care, wound and tissue management, and regenerative healing. It has even unlocked new potential in regenerative healing with the right mix of biologics and synthetics. The other major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising number of chronic diseases related surgeries, and strong focus on R&D leading to the launch of new and advanced products.

Heart failure is a chronic progressive condition that affects the pumping power of the heart muscles. Heart failure refers to a stage in which fluid builds up around the heart and makes it in-efficient in pumping. Humans have a four-chambered heart the upper half of the heart has two atria and the lower portion of the heart has two ventricles. The ventricles pump the blood to body organs, and tissues and atria receive the blood from the body to circulate the blood. There are two types of left ventricular failure, such as systolic heart failure and diastolic heart failure. The systolic heart failure is when the left ventricle fails to contract normally, whereas the diastolic dysfunction is when the heart muscle in the left ventricle becomes stiff.

The market studied is currently being driven by factors, such as the rising incidence of breast cancer, an increasing number of breast augmentation procedures, and technological advancements. Currently, breast cancer is the leading cause of cancer-related deaths among women in the world's developing regions. According to the National Cancer Institute, an estimated number of 252,710 women were diagnosed with breast cancer in 2017. Furthermore, 230,815 American women were diagnosed with breast cancer in 2013. Over 3.1 million American women were affected by breast cancer, as of March 2017. Moreover, it is estimated that the risk of an individual dying from breast cancer may increase in the coming years.

Allergy plays a significant role in patients with atopic dermatitis. The disease mostly flares up when the patient is around the things that cause allergic reactions. It is particularly common in infants and children, who are estimated to be about 10-20% having eczema, as mentioned under the American College of Allergy, Asthma & Immunology. There is a growing number of foundations, which are raising awareness regarding eczema and different types of dermatitis across various regions. The developed regions have a higher prevalence, as well as population, which is more active toward early detection of chronic autoimmune diseases. Thus, the role of rising campaigns each year is very important to fuel the growth of atopic dermatitis market. In March 2017, Sanofi and Regeneron Pharmaceuticals, Inc. announced US FDA approval of Dupixent (dupilumab) Injection. Following the approval, Dupixent was launched as a pre-filled syringe, which can be self- administered as a subcutaneous injection every other week after an initial loading dose. The high potency, long-lasting effect, and ease of administration have made Dupixent one of the most preferred form of Atopic dermatitis treatment method, however, the high annual cost of USD 37,000 can limit the adoption rates.

The Asia Pacific Cochlear Implants market is estimated to grow at a CAGR of 12.5% from 2018 - 2027. Key factors driving the market are rising number of elder population in Asia Pacific and increasing incidences of hearing loss in Asia Pacific. However, high cost associated with cochlear surgeries is anticipated to restrain the market growth in the forecast period. The top 10 industry players operating in the market of Cochlear Implants across the globe includes Cochlear Ltd., MED-EL, Sonova, Nurotron Biotechnology Co. Ltd., Medtronic, Demant A/S, Starkey, WIDEX A/S, Amplifon, and GN Hearing A/S. among the others..

Coronary artery disease (CAD) is the blockage or narrowing of the coronary arteries, that usually occurred by atherosclerosis. Atherosclerosis is the deposit of cholesterol and fatty matters, known as plaque on the inner walls of the arteries. Such buildup can restrict blood flow to the heart muscle by physically blocking the artery. Such a situation can cause chest pain which is called angina. Such cut off of blood supply to a portion of the heart muscle, may cause a heart attack.

The global anti-acne serum market is analyzed on the basis of its prospects and future growth rate. The report highlights numerous factors that influence the growth of the global market. The report discusses the market forecast, drivers, restraints, opportunities, and role of different key players operating in the market. The report covers the revenue generated from the sale of anti-acne serum among males and females. Furthermore, it includes revenue generated from the anti-acne serum across North America, Europe, Asia-Pacific, and LAMEA.

The report provides market dynamics and trends related to the global anti-rheumatics market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of products such as disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others, which are provided by key players. For the purpose of analysis, the global anti-rheumatics market is segmented on the basis of drug class, type, and region. The study estimates the revenue generated from anti-rheumatics. By drug class, the market is divided into disease modifying anti-rheumatics (DMARDs), nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, uric acid drugs, and others. Moreover, for better understanding of the use of anti-rheumatics market, it is further divided by type into prescription-based drugs and over-the-counter drugs. In addition, the report covers revenue generated from the sales of anti-rheumatics in regions such as North America, Europe, Asia-Pacific, and LAMEA.

人类社会发展几千年历史，传染病伴随其中，人类发展史就是一部与传染病作斗争的历史。世界历史较大的几次传染病事件有中世纪欧洲鼠疫，导致当时相当于三分之一欧洲人口的死亡；1918 年西班牙大流感，在1918~1919年曾经造成全球约10 亿人感染，导致2500 万-4000 万人死亡，死亡人数超过一战和二战死亡人数总和；2020 年，新冠肺炎爆发并全球蔓延，截止目前（2020.3.20），全球已经超过25 万感染病例，死亡人数过万人。

我们回顾了2005 年WHO 设立国际关注的突发公共卫生事件（PHEIC）机制以来，除本次新冠疫情外的5 次PHEIC，以及同为冠状病毒引起的非典和MERS疫情。历次疫情涉及六种病毒（甲型H1N1、脊髓灰质、寨卡、两次埃博拉、非典、MERS），截至目前为止对于其疫苗的研发进展：（1）仅有一种病毒的疫苗从立项研发到获批上市，是在疫情的大规模流行期间完成的，即H1N1 甲流疫苗（当时已具备成熟的流感疫苗制备工艺）。（2）共有3 种病毒疫苗目前获批上市，分别为H1N1 甲流疫苗、脊髓灰质疫苗（在该PHEIC 之前早已上市）、埃博拉疫苗（从启动临床I 期到获批注册用时3-5 年）。（3）寨卡疫苗的研发始于15 年，目前最快的进入临床三期；MERS 疫苗最快的16 年进入临床一期，目前进入临床二期；SARS 疫苗的研发先后停摆。